Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening: assessment of current studies

S Shapiro1

  • 1Department of Health Policy and Management, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205-1996.

Cancer
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

System delay in breast cancer in whites and blacks.

American journal of epidemiology·1995
Same author

Extracorporeal pneumoperitoneum access bubble for endoscopic surgery.

American journal of surgery·1995
Same author

An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods.

Journal of clinical epidemiology·1995
Same author

Quantification of thyrotropin-releasing hormone changes and serotonin content changes following graded spinal cord injury.

The Journal of surgical research·1995
Same author

Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Oral contraceptive use and breast cancer risk among African-American women.

Cancer causes & control : CCC·1995
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Routine mammography screening for women aged 40-49 shows uncertain benefits. Evidence suggests focusing on physician guidance regarding mammography

Area of Science:

  • Oncology
  • Public Health
  • Radiology

Background:

  • Determining optimal age ranges for breast cancer screening mammography is a significant public health challenge.
  • Methodological variations across studies, including sample size and mammography quality, complicate the interpretation of screening efficacy.
  • The debate specifically centers on whether to include women aged 40-49 in routine mass screening programs.

Purpose of the Study:

  • To assess the evidence from randomized controlled trials (RCTs) on the effectiveness of mammography screening in different age groups.
  • To evaluate the impact of screening periodicity and modalities on study outcomes.
  • To inform public health policy regarding mammography screening for women aged 40-49.

Main Methods:

  • Analysis of eight randomized controlled trials (RCTs) conducted over three decades in the United States, Europe, and Canada.

Related Experiment Videos

  • Consideration of methodological issues and content variations that influence study conclusions.
  • Examination of screening protocols, including frequency (annual vs. longer intervals) and modality (mammography alone vs. mammography with clinical breast examination).

    • Main Results:

    • Consistent reduction in breast cancer mortality (approximately 30%) observed for women aged 50-69 across all evaluated studies.
    • No clear benefit identified for women aged 40-49 within 5-7 years of study entry; benefits remain uncertain at 10-12 years.
    • Limited long-term data for women aged 40-49 and insufficient data for women aged 70 and older.

    Conclusions:

    • Public health policy supporting routine mammography for women aged 40-49 is currently questionable due to uncertain benefits.
    • Physicians should advise patients about the uncertainty of benefits when considering mammography referrals for this age group.
    • Further research and long-term follow-up are necessary to definitively establish screening efficacy for younger age groups.